Total Payments
$2,837
2024 Payments
$131.59
Companies
21
Transactions
83
Medicare Patients
1,051
Medicare Billing
$52,254
Payment Breakdown by Category
Food & Beverage$1,760 (62.0%)
Travel$1,077 (38.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,760 | 77 | 62.0% |
| Travel and Lodging | $1,077 | 6 | 38.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Intuitive Surgical, Inc. | $1,410 | 10 | $0 (2020) |
| ABBVIE INC. | $329.87 | 17 | $0 (2023) |
| Astellas Pharma US Inc | $255.90 | 12 | $0 (2024) |
| Hologic, LLC | $165.17 | 5 | $0 (2021) |
| MINERVA SURGICAL, INC | $134.94 | 2 | $0 (2017) |
| Amgen Inc. | $94.48 | 7 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $56.87 | 4 | $0 (2022) |
| MAYNE PHARMA COMMERCIAL LLC | $55.44 | 6 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $45.09 | 3 | $0 (2024) |
| Avanos Medical | $41.14 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $131.59 | 8 | Astellas Pharma US Inc ($59.77) |
| 2023 | $218.37 | 12 | Astellas Pharma US Inc ($84.38) |
| 2022 | $116.94 | 8 | ABBVIE INC. ($52.96) |
| 2021 | $227.25 | 9 | Hologic, LLC ($142.80) |
| 2020 | $508.66 | 3 | Intuitive Surgical, Inc. ($486.58) |
| 2019 | $1,127 | 18 | Intuitive Surgical, Inc. ($885.85) |
| 2018 | $249.10 | 18 | AbbVie, Inc. ($51.09) |
| 2017 | $258.19 | 7 | MINERVA SURGICAL, INC ($134.94) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Biological | ||||||
| 10/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Biological | ||||||
| 07/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Biological | ||||||
| 06/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: VACCINE | ||||||
| 05/14/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: VACCINE | ||||||
| 04/18/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $11.60 | General |
| 03/22/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: HORMONE THERAPY | ||||||
| 10/12/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: HORMONE THERAPY | ||||||
| 09/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $84.38 | General |
| Category: Biological | ||||||
| 09/05/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: HORMONE THERAPY | ||||||
| 06/29/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: WOMENS HEALTH | ||||||
| 06/08/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $11.20 | General |
| 06/07/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: WOMENS HEALTH | ||||||
| 05/26/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $4.73 | General |
| 05/02/2023 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: WOMENS HEALTH | ||||||
| 04/18/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $12.35 | General |
| 02/09/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $10.36 | General |
| 01/31/2023 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: WOMENS HEALTH | ||||||
| 01/07/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $5.20 | General |
| 07/18/2022 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Urology | ||||||
| 06/03/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: WOMENS HEALTH | ||||||
| 05/12/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: WOMENS HEALTH | ||||||
| 04/11/2022 | Mylan Pharmaceuticals Inc. | Xulane (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Contraceptives, Transdermal | ||||||
| 04/01/2022 | Mylan Pharmaceuticals Inc. | Xulane (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Contraceptives, Transdermal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 274 | 302 | $56,195 | $13,237 |
| 2022 | 5 | 306 | 336 | $63,999 | $16,113 |
| 2021 | 5 | 255 | 279 | $52,476 | $13,690 |
| 2020 | 5 | 216 | 235 | $35,680 | $9,214 |
Total Patients
1,051
Total Services
1,152
Medicare Billing
$52,254
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 110 | $34,100 | $7,194 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 30 | $12,780 | $3,053 | 23.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 28 | 28 | $4,088 | $1,324 | 32.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 29 | 29 | $3,799 | $1,229 | 32.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 91 | 91 | $1,274 | $390.39 | 30.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 14 | $154.00 | $47.74 | 31.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 109 | $33,790 | $7,980 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 37 | $15,762 | $3,372 | 21.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 59 | 59 | $7,729 | $2,570 | 33.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 37 | 37 | $5,402 | $1,794 | 33.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2022 | 94 | 94 | $1,316 | $397.79 | 30.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 100 | $28,892 | $7,124 | 24.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 31 | 38 | $15,252 | $3,785 | 24.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 31 | 31 | $4,028 | $1,359 | 33.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 21 | 21 | $3,058 | $1,031 | 33.7% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2021 | 89 | 89 | $1,246 | $389.82 | 31.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 92 | $22,264 | $5,228 | 23.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 37 | 37 | $4,736 | $1,641 | 34.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 14 | 15 | $5,310 | $1,247 | 23.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 16 | 16 | $2,320 | $769.88 | 33.2% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2020 | 75 | 75 | $1,050 | $327.78 | 31.2% |
About Dr. David Hulbert, M.D
Dr. David Hulbert, M.D is a Obstetrics & Gynecology healthcare provider based in Willingboro, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1609864370.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hulbert, M.D has received a total of $2,837 in payments from pharmaceutical and medical device companies, with $131.59 received in 2024. These payments were reported across 83 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,760).
As a Medicare-enrolled provider, Hulbert has provided services to 1,051 Medicare beneficiaries, totaling 1,152 services with total Medicare billing of $52,254. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Willingboro, NJ
- Active Since 10/07/2005
- Last Updated 05/11/2011
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1609864370
Products in Payments
- Da Vinci Surgical System (Device) $1,410
- Veozah (Drug) $144.15
- ACESSA PROVU SYSTEM (Device) $142.80
- ENDOMETRIAL ABLATION SYSTEM (Device) $134.94
- Orilissa (Drug) $132.57
- LO LOESTRIN FE (Drug) $85.17
- Prolia (Biological) $81.58
- Myrbetriq (Drug) $52.28
- VESICARE (Drug) $48.27
- MYFEMBREE (Drug) $45.09
- ORIAHNN (Drug) $42.34
- ON-Q PUMP AND ACCESSORIES (Device) $41.14
- Xulane (Drug) $35.55
- GARDASIL (Biological) $30.04
- Kyleena (Drug) $29.28
- ORILISSA (Drug) $29.22
- SOLOSEC (Drug) $27.07
- HARMONIC Product Family (Device) $26.10
- MyoSure (Device) $22.37
- TruClear (Device) $22.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Willingboro
Dr. Kenneth Chen, D. O, D. O
Obstetrics & Gynecology — Payments: $3,892
Obstetrics & Gynecology $3,892
Dr. Michael Snyder, M.d, M.D
Obstetrics & Gynecology — Payments: $1,946
Obstetrics & Gynecology $1,946
Dr. Ashley Hammer, M.d, M.D
Obstetrics & Gynecology — Payments: $1,928
Obstetrics & Gynecology $1,928
Michael Zalkin, M.d, M.D
Obstetrics & Gynecology — Payments: $1,926
Obstetrics & Gynecology $1,926
Francine Siegel, M.d, M.D
Obstetrics & Gynecology — Payments: $1,259
Obstetrics & Gynecology $1,259
Misa Belazi, Md, MD
Obstetrics & Gynecology — Payments: $1,248
Obstetrics & Gynecology $1,248